Cargando…

Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial

Background and Purpose: The aim of this study was to evaluate the efficacy, safety, and tolerability of cerebrolysin in the early recovery phase after acute ischemic stroke. Methods. This prospective, randomized, double-blinded, placebo-controlled, multicenter, parallel-group study enrolled a total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gharagozli, K, Harandi, AA, Houshmand, S, Akbari, N, Muresanu, DF, Vester, J, Winter, S, Moessler, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652261/ https://www.ncbi.nlm.nih.gov/pubmed/29075343

Ejemplares similares

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
por: Muresanu, Dafin F., et al.
Publicado: (2016)

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials
por: Guekht, Alla, et al.
Publicado: (2017)

Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery
por: Jianu, DC, et al.
Publicado: (2010)

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022)

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials
por: Bornstein, Natan M., et al.
Publicado: (2017)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020)

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2023)

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
por: Alvarez, X. Anton, et al.
Publicado: (2016)

Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage
por: Woo, Peter Y. M., et al.
Publicado: (2020)

Role of Cerebrolysin(®) in Rehabilitation in Ischemic Stroke: A Case Report
por: Chanubol, Ratanapat, et al.
Publicado: (2021)

Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study
por: Stan, A, et al.
Publicado: (2017)

Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
por: Wang, Zefeng, et al.
Publicado: (2017)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014)

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study
por: Pakdaman, Hossein, et al.
Publicado: (2017)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009)

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
por: Amiri-Nikpour, Mohammad Reza, et al.
Publicado: (2014)

Cerebrolysin Combined with Rehabilitation Enhances Motor Recovery and Prevents Neural Network Degeneration in Ischemic Stroke Patients with Severe Motor Deficits
por: Chang, Won Hyuk, et al.
Publicado: (2021)

Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
por: Formichi, Patrizia, et al.
Publicado: (2012)

Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Danfeng, et al.
Publicado: (2017)

Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study
por: Khasanova, Dina R., et al.
Publicado: (2023)

Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke
por: Chang, Won Hyuk, et al.
Publicado: (2016)

Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke
por: Stanca, DM, et al.
Publicado: (2015)

Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017)

Use of Cerebrolysin in combination with high‐dose aspirin antithrombotic treatment of ischemic stroke: A case report
por: Borisevich, Alexander, et al.
Publicado: (2021)

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
por: Verisezan Rosu, Olivia, et al.
Publicado: (2023)

The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury
por: Birle, Codruta, et al.
Publicado: (2020)

Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial
por: Ni, Jun, et al.
Publicado: (2020)

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
por: Mureșanu, Ioana Anamaria, et al.
Publicado: (2022)

Effects of cerebrolysin on nerve growth factor system in the aging rat brain
por: Stepanichev, Mikhail, et al.
Publicado: (2017)

Towards a roadmap in brain protection and recovery
por: Muresanu, Dafin F, et al.
Publicado: (2012)

Myasthenia Gravis Development and Crisis Subsequent to Multiple Sclerosis
por: Gharagozli, Kurosh, et al.
Publicado: (2011)

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)

Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials
por: Strilciuc, Stefan, et al.
Publicado: (2021)

Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial
por: Harandi, A. A., et al.
Publicado: (2011)

Low-frequency rTMS in patients with subacute ischemic stroke: clinical evaluation of short and long-term outcomes and neurophysiological assessment of cortical excitability
por: Blesneag, AV, et al.
Publicado: (2015)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
por: Jarosz, Konrad, et al.
Publicado: (2023)

Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial
por: Aimi, Masahito, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oquj98kup4l75jj3i7kelltoq7